mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0007 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |